# Mount Sinai School of Medicine IRB #5 - Board D - Inspection Records

Source: https://www.keypedia.com/companies/mount-sinai-school-of-medicine-irb-5-board-d/a6b5024c-2050-41a5-a6fd-37dc69601e9f

> Inspection records and compliance data for Mount Sinai School of Medicine IRB #5 - Board D in Suite 200 New York, NY. Access full analysis and detailed observations.

---

## Details

- Name: Mount Sinai School of Medicine IRB #5 - Board D
- FEI Number: 2431541
- City: Suite 200 New York
- State: NY
- Country Name: United States
- Address Line 1: 345 East 102nd Street
- Zip Code: 10029-6504

## Related Documents

- [FDA Inspection 1312826 - Mount Sinai School of Medicine IRB #5 - Board D - 2026-03-25](https://www.keypedia.com/records/fda_inspections/mount-sinai-school-of-medicine-irb-5-board-d/8b12d987-8ba7-430e-8de9-9ea37d42be88) — source: FDA, date: March 25, 2026
- [FDA Inspection 1312826 - Mount Sinai School of Medicine IRB #5 - Board D - 2026-03-25](https://www.keypedia.com/records/fda_inspections/mount-sinai-school-of-medicine-irb-5-board-d/2799eb13-d465-43fd-af5f-c2db28000f53) — source: FDA, date: March 25, 2026
- [FDA Inspection 1312826 - Mount Sinai School of Medicine IRB #5 - Board D - 2026-03-25](https://www.keypedia.com/records/fda_inspections/mount-sinai-school-of-medicine-irb-5-board-d/5fdb3698-1b62-4ef9-91ab-e8fce66f36a5) — source: FDA, date: March 25, 2026
- [FDA Inspection 1047499 - Mount Sinai School of Medicine IRB #5 - Board D - 2018-03-22](https://www.keypedia.com/records/fda_inspections/mount-sinai-school-of-medicine-irb-5-board-d/cd24744c-bb27-48a0-9e4f-4380329a2948) — classification: No Action Indicated (NAI), source: FDA, date: March 22, 2018
- [FDA Inspection 1047499 - Mount Sinai School of Medicine IRB #5 - Board D - 2018-03-22](https://www.keypedia.com/records/fda_inspections/mount-sinai-school-of-medicine-irb-5-board-d/7a449963-dbd3-4058-ac96-514dceca80ab) — classification: No Action Indicated (NAI), source: FDA, date: March 22, 2018
- [EIR - Mount Sinai School of Medicine IRB #5 - Board D - 2014-01-31](https://www.keypedia.com/records/eir/mount-sinai-school-of-medicine-irb-5-board-d/601dee8f-87b0-4bb3-85c2-84e8d71cb0a8) — source: FDA, date: January 31, 2014
- [FDA Inspection 863841 - Mount Sinai School of Medicine IRB #5 - Board D - 2014-01-31](https://www.keypedia.com/records/fda_inspections/mount-sinai-school-of-medicine-irb-5-board-d/b7343f7f-2f9b-4ae9-81a9-6d6096f25b7c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 31, 2014

## Related Companies

- [Philips Respironics, Inc.](https://www.keypedia.com/companies/philips-respironics-inc/03ceee46-7a72-4590-8bc4-8033e1503cf3)
- [Reading Hospital](https://www.keypedia.com/companies/reading-hospital/06325159-9820-479a-ba2e-0f47aaa24d60)
- [Prolacta Bioscience Inc](https://www.keypedia.com/companies/prolacta-bioscience-inc/fafc52a9-8c2a-4c2a-9889-e42779d7c654)
- [Dermarite Industries, LLC.](https://www.keypedia.com/companies/dermarite-industries-llc/72e65a9b-c9c7-44e1-a73a-fd807ffb77d3)
- [Better Water LLC](https://www.keypedia.com/companies/better-water-llc/b12935ac-d3c6-48b4-b65e-62c73611b9f5)
- [US Vascular, Inc.](https://www.keypedia.com/companies/us-vascular-inc/32500e78-94f1-4fba-8df5-32eccb7cc967)
- [National Biological Corp](https://www.keypedia.com/companies/national-biological-corp/2ea6c746-7d5e-43ca-bc6f-ced3c21c9311)
- [Everything Sprouts, LLC](https://www.keypedia.com/companies/everything-sprouts-llc/d8ac40b4-d290-4435-b87d-4f3439e94693)
- [BURTON MEDICAL](https://www.keypedia.com/companies/burton-medical/4cd7a15c-6124-4d31-8f3f-f3f3c5f38c08)
- [Georgia Eye Bank, Inc.](https://www.keypedia.com/companies/georgia-eye-bank-inc/6fb2513a-c7e5-4957-9e38-fea6c411fb9a)

## Related Officers

- [Consumer Safety Officer at FDA](https://www.keypedia.com/people/joy-ann-p-matthias/129f51c0-e0ba-45a9-b4c3-921f0178351a)
- [investigator](https://www.keypedia.com/people/thomas-p-hansen/2b3af3e0-445c-460b-be6f-6db03999ff7e)